Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1429-1440
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Characteristic | Before PSM | After PSM | ||||
Dual etiology, n = 755 | HBV alone, n = 1373 | P value | Dual etiology, n = 755 | HBV alone, n = 755 | P value | |
Age, year | 53.83 ± 9.62 | 53.87 ± 9.72 | 0.932 | 53.83 ± 9.62 | 53.80 ± 9.58 | 0.957 |
Male | 324 (42.91) | 451 (32.85) | < 0.001 | 324 (42.91) | 324 (42.91) | > 0.999 |
BMI, kg/m2 | 26.25 ± 3.69 | 23.00 ± 3.07 | < 0.001 | 26.25 ± 3.69 | 23.05 ± 3.09 | < 0.001 |
Body fat % | 31.32 ± 7.66 | 27.20 ± 7.27 | < 0.001 | 31.32 ± 7.66 | 26.04 ± 7.60 | < 0.001 |
WC, cm | 88.76 ± 10.41 | 80.24 ± 8.88 | < 0.001 | 88.76 ± 10.41 | 80.45 ± 8.87 | < 0.001 |
Metabolic parameters | ||||||
Diabetes | 135 (17.88) | 69 (5.03) | < 0.001 | 135 (17.88) | 41 (5.43) | < 0.001 |
Hypertension | 153 (20.26) | 140 (10.20) | < 0.001 | 153 (20.26) | 81 (10.73) | < 0.001 |
Hyperlipidemia | 93 (12.32) | 89 (6.48) | < 0.001 | 93 (12.32) | 58 (7.68) | 0.003 |
Glucose, mg/dL | 102 (26.32) | 93 (16.97) | < 0.001 | 102 (26.32) | 94 (20.10) | < 0.001 |
HbA1c, % | 6.11 ± 1.06 | 5.68 ± 0.62 | < 0.001 | 6.11 ± 1.06 | 5.69 ± 0.70 | < 0.001 |
TG, mg/dL | 139.82 ± 96.00 | 90.08 ± 50.25 | < 0.001 | 139.82 ± 96.00 | 91.52 ± 51.42 | < 0.001 |
CHO, mg/dL | 196.49 ± 38.11 | 193.06 ± 34.35 | 0.040 | 196.49 ± 38.11 | 193.44 ± 34.53 | 0.104 |
HDL, mg/dL | 49.71 ± 11.55 | 58.27 ± 13.73 | < 0.001 | 49.71 ± 11.55 | 57.96 ± 13.89 | < 0.001 |
LDL, mg/dL | 123.25 ± 33.16 | 116.55 ± 29.91 | < 0.001 | 123.25 ± 33.16 | 117.00 ± 30.02 | < 0.001 |
Liver parameters | ||||||
AST, U/L | 28.70 ± 13.27 | 27.56 ± 16.69 | 0.084 | 28.70 ± 13.27 | 28.10 ± 15.93 | 0.426 |
ALT, U/L | 33.40 ± 26.16 | 25.91 ± 31.13 | < 0.001 | 33.40 ± 26.16 | 27.29 ± 34.92 | < 0.001 |
GGT, U/L | 24.21 ± 16.74 | 17.73 ± 20.46 | < 0.001 | 24.21 ± 16.74 | 18.88 ± 23.99 | < 0.001 |
Fatty liver index | 37.72 ± 23.66 | 15.09 ± 15.64 | < 0.001 | 37.72 ± 23.66 | 15.85 ± 16.07 | < 0.001 |
FIB-4 | 1.35 ± 0.64 | 1.57 ± 0.80 | < 0.001 | 1.35 ± 0.64 | 1.61 ± 0.78 | < 0.001 |
FIB-4 > 2 | 100 (13.25) | 307 (22.36) | < 0.0001 | 100 (13.25) | 185 (24.50) | < 0.001 |
Other parameters | ||||||
Carotid plaque | 198 (26.23) | 335 (24.40) | 0.352 | 198 (26.23) | 194 (25.70) | 0.814 |
- Citation: Wang SW, Chang YW, Wang C, Cheng YM, Hsieh TH, Wang CC, Kao JH. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World J Hepatol 2024; 16(12): 1429-1440
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1429.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1429